Skip to main content

Janux Therapeutics, Inc.

JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001817713

No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Janux Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
54
+6 vs. Q1 2023
Shares held
30.5M
−33.1K (−0.1%) vs. Q1 2023
Total value
$362.1M
−$7.41M (−2.0%) vs. Q1 2023
New holders
11
18 more added
Sold out
5
14 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 54 institutions
Q1 2021: 0 institutionsQ2 2021: 30 institutionsQ3 2021: 45 institutionsQ4 2021: 46 institutionsQ1 2022: 47 institutionsQ2 2022: 44 institutionsQ3 2022: 49 institutionsQ4 2022: 50 institutionsQ1 2023: 48 institutionsQ2 2023: 54 institutionsQ3 2023: 57 institutionsQ4 2023: 64 institutionsQ1 2024: 121 institutionsQ2 2024: 155 institutionsQ3 2024: 160 institutionsQ4 2024: 216 institutionsQ1 2025: 181 institutionsQ2 2025: 174 institutionsQ3 2025: 174 institutionsQ4 2025: 176 institutionsQ1 2026: 190 institutionsQ2 2026: 197 institutions
Value heldQ2 2023: $362.1M
Q1 2021: $0Q2 2021: $614.5MQ3 2021: $571.2MQ4 2021: $541.6MQ1 2022: $407.1MQ2 2022: $353.0MQ3 2022: $400.3MQ4 2022: $381.3MQ1 2023: $369.5MQ2 2023: $362.1MQ3 2023: $354.0MQ4 2023: $359.5MQ1 2024: $1.59BQ2 2024: $1.87BQ3 2024: $2.07BQ4 2024: $3.43BQ1 2025: $1.81BQ2 2025: $1.51BQ3 2025: $1.59BQ4 2025: $860.0MQ1 2026: $827.8MQ2 2026: $933.4M
Institutions holding JANX and their total value by quarter
QuarterHoldersValue
Q2 2026197$933.4M
Q1 2026190$827.8M
Q4 2025176$860.0M
Q3 2025174$1.59B
Q2 2025174$1.51B
Q1 2025181$1.81B
Q4 2024216$3.43B
Q3 2024160$2.07B
Q2 2024155$1.87B
Q1 2024121$1.59B
Q4 202364$359.5M
Q3 202357$354.0M
Q2 202354$362.1M
Q1 202348$369.5M
Q4 202250$381.3M
Q3 202249$400.3M
Q2 202244$353.0M
Q1 202247$407.1M
Q4 202146$541.6M
Q3 202145$571.2M
Q2 202130$614.5M
Q1 20210$0

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding JANX in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.8,670,644$102.9M1.94%00.0%Unchanged
FMR LLC5,062,796$60.1M0.01%−77,848−1.5%Reduced
BVF Inc4,106,945$48.7M1.36%+2,521,268+159.0%Added
OrbiMed Advisors LLC2,836,386$33.7M0.66%00.0%Unchanged
Citadel Advisors LLC2,115,574$25.1M0.03%+262,548+14.2%Added
Janus Henderson Group PLC2,109,338$25.0M0.02%+240,262+12.9%Added
BlackRock Inc.1,194,588$14.2M0.00%+59,943+5.3%Added
Adage Capital Partners GP, L.L.C.900,000$10.7M0.02%00.0%Unchanged
Vanguard Group Inc761,990$9.04M0.00%−10,665−1.4%Reduced
EcoR1 Capital, LLC452,590$5.37M0.14%−3,385,896−88.2%Reduced
Geode Capital Management, LLC377,225$4.48M0.00%+22,640+6.4%Added
Samsara BioCapital, LLC360,414$4.28M0.75%00.0%Unchanged
State Street Corp332,590$3.95M0.00%+33,961+11.4%Added
Northern Trust Corp187,290$2.22M0.00%+47,319+33.8%Added
JPMorgan Chase & Co153,436$1.82M0.00%+23,779+18.3%Added
Millennium Management LLC138,246$1.64M0.00%+104,143+305.4%Added
Woodline Partners LP137,300$1.63M0.02%00.0%Unchanged
Cerity Partners LLC60,933$723.3K0.00%+60,933New
Nuveen Asset Management, LLC58,745$697.3K0.00%+12,842+28.0%Added
Bank of New York Mellon Corp53,049$629.7K0.00%−42−0.1%Reduced
DekaBank Deutsche Girozentrale49,500$571.0K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc46,121$547.5K0.00%+729+1.6%Added
Squarepoint Ops LLC27,780$329.7K0.00%+14,613+111.0%Added
Rhumbline Advisers26,778$317.9K0.00%−71−0.3%Reduced
Swiss National Bank22,800$270.6K0.00%−4,200−15.6%Reduced
Goldman Sachs Group Inc22,719$269.7K0.00%+22,719New
Bank of America Corp21,147$251.0K0.00%−2,590−10.9%Reduced
Morgan Stanley18,481$219.4K0.00%−15,023−44.8%Reduced
Credit Suisse AG15,899$188.7K0.00%+15,899New
Alliancebernstein L.P.15,030$178.4K0.00%+15,030New
California State Teachers Retirement System14,952$177.5K0.00%−2,379−13.7%Reduced
Jane Street Group, LLC14,935$177.3K0.00%+14,935New
Renaissance Technologies LLC14,800$176.0K0.00%+14,800New
XTX Topco Ltd13,215$156.9K0.03%+13,215New
State of Wisconsin Investment Board13,202$156.7K0.00%+1,647+14.3%Added
Qube Research & Technologies Ltd12,641$150.0K0.00%+12,641New
Jump Financial, LLC10,821$128.4K0.00%+10,821New
MetLife Investment Management10,614$126.0K0.00%00.0%Unchanged
Legal & General Group Plc10,194$121.0K0.00%+5,484+116.4%Added
Exchange Traded Concepts, LLC10,010$118.8K0.00%+10,010New
American International Group, Inc.8,324$98.8K0.00%+42+0.5%Added
Deutsche Bank AG6,973$82.8K0.00%−3,485−33.3%Reduced
Wells Fargo & Company6,633$78.7K0.00%+3,548+115.0%Added
Citigroup Inc5,787$68.7K0.00%+5,228+935.2%Added
Barclays PLC5,479$65.0K0.00%−3,425−38.5%Reduced
New York State Common Retirement Fund5,030$59.7K0.00%−8,218−62.0%Reduced
Amalgamated Bank1,766$21.0K0.00%−18−1.0%Reduced
Royal Bank of Canada1,783$21.0K0.00%+823+85.7%Added
Tower Research Capital LLC (TRC)1,597$19.0K0.00%−1,747−52.2%Reduced
Russell Investments Group, Ltd.1,532$18.2K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.1,014$12.0K0.00%00.0%Unchanged
Metropolitan Life Insurance Co1,004$11.9K0.00%00.0%Unchanged
Lindbrook Capital, LLC125$1.48K0.00%+125New
US Bancorp90$1.07K0.00%00.0%Unchanged
Vident Investment Advisory, LLC0$00.00%−55,483−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−12,728−100.0%Sold out
UBS Group AG0$00.00%−841−100.0%Sold out
Tucker Asset Management LLC0$00.00%−250−100.0%Sold out
Crewe Advisors LLC0$00.00%−115−100.0%Sold out